BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 14561179)

  • 1. Emerging treatments for autoimmune hepatitis.
    Czaja AJ
    Curr Drug Targets Inflamm Allergy; 2002 Dec; 1(4):317-26. PubMed ID: 14561179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of autoimmune hepatitis.
    Czaja AJ
    Semin Liver Dis; 2002 Nov; 22(4):365-78. PubMed ID: 12447708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment strategies in autoimmune hepatitis.
    Czaja AJ
    Clin Liver Dis; 2002 Aug; 6(3):799-824. PubMed ID: 12362582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolving new therapies of autoimmune hepatitis.
    Vierling JM; Flores PA
    Clin Liver Dis; 2002 Aug; 6(3):825-50, ix. PubMed ID: 12362583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promising pharmacological, molecular and cellular treatments of autoimmune hepatitis.
    Czaja AJ
    Curr Pharm Des; 2011; 17(29):3120-40. PubMed ID: 21902661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging opportunities for site-specific molecular and cellular interventions in autoimmune hepatitis.
    Czaja AJ
    Dig Dis Sci; 2010 Oct; 55(10):2712-26. PubMed ID: 20108036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug therapy in the management of type 1 autoimmune hepatitis.
    Czaja AJ
    Drugs; 1999 Jan; 57(1):49-68. PubMed ID: 9951951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmune hepatitis: focusing on treatments other than steroids.
    Czaja AJ
    Can J Gastroenterol; 2012 Sep; 26(9):615-20. PubMed ID: 22993733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current and future treatments of autoimmune hepatitis.
    Czaja AJ
    Expert Rev Gastroenterol Hepatol; 2009 Jun; 3(3):269-91. PubMed ID: 19485809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current and prospective pharmacotherapy for autoimmune hepatitis.
    Czaja AJ
    Expert Opin Pharmacother; 2014 Aug; 15(12):1715-36. PubMed ID: 24961409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current therapy for autoimmune hepatitis.
    Montano Loza AJ; Czaja AJ
    Nat Clin Pract Gastroenterol Hepatol; 2007 Apr; 4(4):202-14. PubMed ID: 17404588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transplant immunosuppressive agents in non-transplant chronic autoimmune hepatitis: the Canadian association for the study of liver (CASL) experience with mycophenolate mofetil and tacrolimus.
    Chatur N; Ramji A; Bain VG; Ma MM; Marotta PJ; Ghent CN; Lilly LB; Heathcote EJ; Deschenes M; Lee SS; Steinbrecher UP; Yoshida EM
    Liver Int; 2005 Aug; 25(4):723-7. PubMed ID: 15998421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of immunosuppression in autoimmune hepatitis: A current literature review.
    Cropley A; Weltman M
    Clin Mol Hepatol; 2017 Mar; 23(1):22-26. PubMed ID: 28288505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histological changes after the use of mycophenolate mofetil in autoimmune hepatitis.
    Brunt EM; Di Bisceglie AM
    Hum Pathol; 2004 Apr; 35(4):509-12. PubMed ID: 15116334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and Management of Autoimmune Hepatitis: Current Status and Future Directions.
    Czaja AJ
    Gut Liver; 2016 Mar; 10(2):177-203. PubMed ID: 26934884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Empiric therapy of autoimmune hepatitis with mycophenolate mofetil: comparison with conventional treatment for refractory disease.
    Czaja AJ; Carpenter HA
    J Clin Gastroenterol; 2005 Oct; 39(9):819-25. PubMed ID: 16145346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmune hepatitis: From current knowledge and clinical practice to future research agenda.
    Sebode M; Hartl J; Vergani D; Lohse AW;
    Liver Int; 2018 Jan; 38(1):15-22. PubMed ID: 28432836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis in patients resistant to or intolerant of azathioprine.
    Richardson PD; James PD; Ryder SD
    J Hepatol; 2000 Sep; 33(3):371-5. PubMed ID: 11019991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promising treatment of autoimmune hepatitis with 6-thioguanine after adverse events on azathioprine.
    de Boer NK; van Nieuwkerk CM; Aparicio Pages MN; de Boer SY; Derijks LJ; Mulder CJ
    Eur J Gastroenterol Hepatol; 2005 Apr; 17(4):457-61. PubMed ID: 15756101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune responses in autoimmune hepatitis: effect of prednisone and azathioprine treatment: case report.
    Bluth MH; Kohlhoff S; Norowitz KB; Silverberg JI; Chice S; Nowakowski M; Durkin HG; Smith-Norowitz TA
    Int J Med Sci; 2009 Jun; 6(4):177-83. PubMed ID: 19584951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.